Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Memory, Roche Widen Deal To Try Nicotinic Alpha-7 Agonist In Schizophrenia

Feb 19 2008

• By Shirley Haley

Related Content

Memory, Roche Rewrite Deal To Support Phase IIa Trial In Schizophrenia Cognitive Impairment Treatment

Jun 20 2007

Memory Alzheimer’s Disease Candidate Shows Cognitive Benefit In Phase II

Nov 02 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window